Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Rafarma Pharmaceuticals, Inc. (RAFA) Boasts The Newest And Most Advanced Pharmaceutical Facilities In Russia 0 comments
    May 8, 2013 1:46 PM

    Though new, Rafarma Pharmaceuticals already holds a unique position in the pharmaceutical industry, representing the most advanced pharmaceutical operations in Russia. The company is focused on the production of generic antibiotics and specialty pharmaceuticals, with the goal of becoming one of the country's top antibiotic producers over the next 5 years and obtaining a 5% share of the overall Russian pharmaceutical market in just 3 years. Underpinning this strategic goal is the plan to reduce prices on certain key pharmaceutical products by 30%-40%, a move that is expected to help reduce dependence upon western suppliers.

    In addition Rafarma plans on developing its own in-house developed and generic pharmaceuticals, as well as identifying potential acquisition targets, including brands, trademarks, and other marketing assets. They also expect to engage in joint products with foreign pharmaceutical companies.

    Initially targeted, and applied for, generic medications include the following:

    • Anti-cancer drugs (5)

    • Anti-microbe and infection drugs (20)

    • Heart health drugs (4)

    • Anti-ulcer drugs (3)

    • Neuroleptics (3)

    • Others (2)

    Self-developed products include anti-bacterial, anti-viral, anti-infection based products, currently in clinical trials, and patented instruments for medical use (inhaler, injector). The company is working with Christian Albrecht University in Germany to develop drug and related delivery products.

    Underlying these developments is the company's stated social responsibility strategy, corresponding with the government's goal of achieving complete independence from high-cost imported medications while maintaining top international standards.

    For more information, visit rafarma.us

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.